Amdocs
DOX
$51.47
-6.33%
Amdocs Limited is a global provider of software and services primarily to communications, entertainment, and media service providers, operating within the Software - Infrastructure industry. The company is a well-established player, offering a portfolio that spans digital business systems, legacy business and operational support systems (BSS/OSS), and cloud-native solutions designed to support its clients' digital transformation, cloud adoption, and network automation initiatives. The current investor narrative centers on the company's execution within a challenging macro environment for its telecom and media clients, with recent attention focused on its ability to maintain growth and profitability amidst sector-specific headwinds and competitive pressures, as reflected in its recent stock price weakness.…
DOX
Amdocs
$51.47
Investment Opinion: Should I buy DOX Today?
Rating & Thesis: Hold. DOX presents a deeply conflicted profile where compelling valuation is offset by powerful negative momentum; investors should wait for evidence of a trend reversal before committing capital. The limited analyst coverage shows maintained 'Buy'/'Overweight' ratings from some firms, but the lack of a broad consensus target price underscores the uncertainty.
Supporting Evidence: The primary valuation metric, a forward P/E of 6.97x, is exceptionally low and suggests deep value if earnings materialize. Revenue growth, while stable at 4.13% YoY, is not accelerating. Profitability is a strength, with a solid net margin of 13.63% and robust TTM free cash flow of $754.9 million. However, the stock's technical posture is abysmal, trading just 1.9% above its 52-week low after a -40.05% annual decline, indicating a complete lack of bullish conviction.
Risks & Conditions: The two biggest risks are 1) a break below the $55.27 support extending the downtrend, and 2) a failure to meet the high forward EPS estimate, crushing the low-PE valuation thesis. This Hold rating would upgrade to a Buy on a confirmed technical reversal above key moving averages accompanied by stable or improving quarterly growth. It would downgrade to a Sell on a decisive break below $55.27 with high volume. Relative to its own history and cash-generative profile, the stock appears undervalued, but it is fairly valued relative to the market's current pessimistic growth outlook.
Sign up to view all
DOX 12-Month Price Forecast
DOX is a classic 'value trap' candidate—fundamentally cheap but lacking a catalyst to arrest its downward momentum. The strong cash flow and low leverage provide a margin of safety, but the market is clearly focused on growth concerns. The stance is neutral due to the high uncertainty; the stock could rally sharply on any positive news given its oversold state, but the path of least resistance remains sideways to down until technical buying emerges. The stance would upgrade to bullish on a confirmed quarterly earnings beat and a technical reversal above $70. It would turn bearish on a breakdown below $55 with no immediate recovery.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Amdocs's 12-month outlook, with a consensus price target around $66.91 and implied upside of +30.0% versus the current price.
Average Target
$66.91
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$41 - $67
Analyst target range
Insufficient analyst coverage is available, with data indicating only one analyst providing estimates. This limited coverage typically signifies a mid-cap stock with subdued institutional interest or one that is under-followed by the sell-side, which can contribute to higher volatility and less efficient price discovery. The single analyst's revenue estimate for the period is approximately $5.49 billion, with a tight EPS estimate range around $11.14. The institutional ratings data shows a mixed but generally stable picture from the few firms that do cover the stock. Recent actions include Barclays maintaining an 'Overweight' and Stifel maintaining a 'Buy' in February 2026, following Wolfe Research downgrading to 'Peer Perform' from 'Outperform' in November 2025. The lack of a broad consensus target price and the wide historical P/E range highlight the uncertainty and lack of clear directional conviction among the limited analyst community. This environment makes the stock more susceptible to company-specific news and quarterly execution rather than broad analyst sentiment shifts.
Bulls vs Bears: DOX Investment Factors
The investment debate for DOX centers on a clash between compelling value and undeniable negative momentum. The bull case is anchored in deep valuation metrics (forward P/E of 6.97x), strong cash generation, and an oversold technical condition near multi-year lows. The bear case is dominated by a severe, persistent downtrend, decelerating growth, and a market that has clearly derated the stock's multiple. Currently, the bearish evidence from price action and momentum is stronger, as the stock has failed to find a bottom despite its cheap valuation. The single most important tension is whether the company's stable profitability and cash flow can eventually outweigh the market's pessimism over its growth prospects. The resolution hinges on DOX demonstrating either a return to stronger revenue growth or the market recognizing its value as a cash-generative defensive asset, thereby arresting the technical decline.
Bullish
- Deeply Undervalued Forward P/E: The stock trades at a forward P/E of 6.97x, which is exceptionally low for a profitable software company. This valuation implies a significant earnings growth expectation from the single analyst, with an EPS estimate of $11.14, or a severe market discount due to negative sentiment.
- Strong Profitability and Cash Flow: Amdocs maintains robust profitability with a net margin of 13.63% in the latest quarter and generates substantial free cash flow, with TTM FCF of $754.9 million. This provides financial flexibility for dividends, buybacks, and investments without high leverage, as evidenced by a low debt-to-equity ratio of 0.24.
- Oversold Technical Condition: The stock is trading just 1.9% above its 52-week low of $55.27, following a -40.05% one-year decline. This deep oversold condition, coupled with a low beta of 0.39, suggests the severe downtrend may be overdone, presenting a potential mean-reversion opportunity.
- Stable, Defensive Business Model: Revenue has shown consistent, albeit slow, sequential growth over the last four quarters, with the latest at $1.156B representing 4.13% YoY growth. This stability, serving essential telecom infrastructure needs, offers defensive characteristics in volatile markets.
Bearish
- Severe Negative Momentum and Trend: The stock has underperformed the S&P 500 by -62.91% over the past year and is down -28.92% over six months. This persistent negative momentum across all timeframes indicates strong selling pressure and a lack of catalysts to reverse the downtrend.
- Growth Deceleration and Sector Headwinds: Revenue growth of 4.13% YoY is modest and reflects the challenging macro environment for telecom and media clients. The sequential revenue pattern shows low-single-digit increases, failing to demonstrate the acceleration needed to justify a premium valuation or re-rate the stock.
- Valuation Derating and Multiple Compression: The trailing P/E has compressed from historical levels above 29x to the current 16.15x. This derating signals the market is no longer willing to pay a growth multiple for the company, reflecting concerns about its long-term growth trajectory within its core markets.
- Limited Analyst Coverage and Visibility: With only one analyst providing estimates, there is insufficient sell-side support and poor visibility into forward expectations. This lack of coverage can lead to higher volatility, inefficient price discovery, and a diminished pool of potential institutional buyers.
DOX Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -40.05% and a 6-month decline of -28.92%, significantly underperforming the broader market. As of the latest close at $56.40, the price is trading near the bottom of its 52-week range (low: $55.27, high: $95.41), positioning it at just 1.9% above its 52-week low. This proximity to multi-year lows suggests the stock is deeply oversold, presenting a potential value opportunity but also indicating significant negative momentum and a lack of positive catalysts to arrest the decline. Recent momentum remains sharply negative, with the stock down -5.89% over the past month and -14.98% over the past three months, confirming the persistence of the longer-term downtrend. The 1-month relative strength of -5.81% versus the S&P 500's slight decline of -0.08% underscores severe underperformance. This consistent negative momentum across all measured timeframes signals strong selling pressure and a lack of near-term bullish conviction from the market. Key technical support is clearly defined at the 52-week low of $55.27, with a decisive break below this level likely signaling a continuation of the downtrend and potentially triggering further technical selling. Immediate resistance lies far above, near the 52-week high of $95.41. The stock's beta of 0.39 indicates it is historically 61% less volatile than the broader market, which is atypical for a technology stock and suggests it has been a relatively defensive holding that has nonetheless experienced a severe, non-volatile grind lower. The max drawdown of -40.43% quantifies the depth of the bearish trend.
Beta
0.39
0.39x market volatility
Max Drawdown
-45.3%
Largest decline past year
52-Week Range
$51-$95
Price range past year
Annual Return
-44.3%
Cumulative gain past year
| Period | DOX Return | S&P 500 |
|---|---|---|
| 1m | -17.1% | +1.8% |
| 3m | -20.6% | +15.1% |
| 6m | -36.0% | +9.7% |
| 1y | -44.3% | +25.0% |
| ytd | -35.8% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DOX Fundamental Analysis
Amdocs's revenue trajectory shows modest but decelerating growth. For the quarter ending December 31, 2025, revenue was $1.156 billion, representing a year-over-year growth of 4.13%. However, examining the sequential trend from the prior four quarters (Q2 2025: $1.128B, Q3 2025: $1.144B, Q4 2025: $1.150B, Q1 2026: $1.156B) reveals a pattern of low-single-digit sequential increases, indicating stable but not accelerating top-line expansion. The company's primary challenge appears to be generating more robust growth in its core markets. The company remains profitable with healthy margins. Net income for the latest quarter was $157.6 million, translating to a net margin of 13.63%. The gross margin for the period was a solid 37.04%, and the operating margin was 17.88%. Over recent quarters, gross margins have been stable in the 36-38% range, while net margins have shown some quarterly variability (e.g., 8.44% in Q4 2025) but generally reflect a profitable enterprise. The trailing twelve-month free cash flow of $754.9 million is a strong positive, indicating robust cash generation from operations. Amdocs maintains a conservative balance sheet with a debt-to-equity ratio of 0.24, indicating low financial leverage. The current ratio of 1.17 suggests adequate short-term liquidity. The company's return on equity (ROE) of 16.47% and return on assets (ROA) of 8.16% demonstrate efficient use of capital. The substantial free cash flow generation, evidenced by a TTM FCF of $754.9 million, provides ample financial flexibility to fund dividends, share buybacks (as seen in cash flow statements), and strategic investments without reliance on external debt.
Quarterly Revenue
$1.2B
2025-12
Revenue YoY Growth
+0.04%
YoY Comparison
Gross Margin
+0.37%
Latest Quarter
Free Cash Flow
$754886999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DOX Overvalued?
Given Amdocs's consistent profitability with a positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The stock currently trades at a trailing P/E of 16.15x and a forward P/E of 6.97x, based on the provided data. The significant discount of the forward P/E relative to the trailing multiple suggests analysts expect a substantial increase in earnings, though the single-analyst EPS estimate of $11.14 for the forward period appears anomalously high and should be viewed with caution due to limited coverage. Compared to typical software infrastructure peers, a trailing P/E of 16.15x appears reasonable to slightly discounted, though a precise industry average is not provided in the data. The stock's Price-to-Sales (P/S) ratio of 2.01 and EV/Sales of 1.48 are not excessive, suggesting the market is not pricing in aggressive growth expectations. The low forward P/E, if credible, would indicate a deep value proposition, but the discrepancy warrants scrutiny of the underlying earnings forecast. Historically, the stock's own valuation has compressed significantly. The current trailing P/E of 16.15x is below the historical P/E ratios seen in recent quarters, which have ranged from the mid-teens to the high 20s (e.g., 23.08x in Q4 2025, 29.09x in Q4 2024). This contraction aligns with the stock's price decline and suggests the market has derated the company due to growth concerns or sector headwinds, moving it from a growth-oriented multiple to a more value-oriented one.
PE
16.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 14x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Amdocs faces risks primarily from its growth trajectory, not its balance sheet. The core risk is revenue growth deceleration to a low-single-digit pace (4.13% YoY), which may be insufficient to support even its compressed valuation if it persists. While profitability is stable with a 13.63% net margin, earnings have shown quarterly volatility, as seen in Q4 2025's net margin of 8.44%. The company's valuation is highly sensitive to these earnings figures; the anomalously high forward EPS estimate of $11.14 from a single analyst creates significant forecast risk, and a miss could trigger another downward re-rating.
Market & Competitive Risks: The predominant market risk is continued multiple compression. The stock's trailing P/E of 16.15x represents a significant derating from historical levels above 29x, but further compression is possible if the sector continues to favor high-growth stories over value. Competitive disruption from cloud-native entrants and pressure on telecom capex budgets pose external threats. The stock's low beta of 0.39 indicates it is less correlated to the broad market, but this has not prevented a severe idiosyncratic decline, highlighting potent company-specific and sector-specific headwinds.
Worst-Case Scenario: The worst-case scenario involves a breakdown of the $55.27 support level, triggering accelerated technical selling amid continued growth disappointment. This could be catalyzed by a guidance cut or a significant earnings miss versus the lofty single-analyst estimate. In this scenario, the stock could re-test levels implied by a further compressed P/E multiple, potentially falling 20-30% from current prices. A realistic downside target would be a re-test of the multi-year low, representing a loss of approximately -35% to the 52-week low of $55.27, extending the already severe -40.43% max drawdown.
FAQ
The key risks are: 1) Momentum & Technical Risk: The stock is in a powerful downtrend and a break below $55.27 could lead to further losses. 2) Growth Risk: Revenue growth of 4.13% may decelerate further amid telecom sector headwinds. 3) Analyst/Visibility Risk: With only one analyst providing estimates, there is poor forward visibility and the stock is susceptible to company-specific news shocks. 4) Valuation Trap Risk: The low P/E may not expand if the market continues to perceive DOX as a low-growth story, leading to permanent capital impairment.
Our 12-month outlook presents three scenarios. The Base Case (60% probability) sees the stock trading between $60 and $70 as it stabilizes, supported by its value metrics but capped by growth concerns. The Bull Case (25% probability) projects a rally to $75-$85 on a mean-reversion driven by earnings beats and technical reversal. The Bear Case (15% probability) warns of a drop to $50-$55 if support breaks and growth disappoints. The Base Case is most likely, assuming the company meets current modest expectations without a positive catalyst to change the narrative.
Based on traditional metrics, DOX appears significantly undervalued. Its forward P/E of 6.97x is exceptionally low for a profitable software company, and its Price-to-Sales ratio of 2.01 is reasonable. However, valuation must be contextualized by growth; the stock is fairly valued or even overvalued if its growth remains stuck at ~4%. The market has derated its trailing P/E from over 29x to 16.15x, indicating it is paying a discount for slower growth expectations. The current valuation implies the market expects stagnation, not a collapse.
DOX is a high-risk, high-potential-reward stock that is not a good buy for most investors at this moment. For deep-value, patient investors, its forward P/E of 6.97x and strong free cash flow ($754.9M TTM) represent a compelling bargain if the company can stabilize. However, the severe -40.05% annual decline and proximity to its 52-week low indicate powerful negative momentum that could continue. It could be a good buy for a contrarian once there is technical evidence of a bottom, such as a sustained move above key resistance levels. For others, it is a 'watch and wait' situation.
DOX is unsuitable for short-term trading due to its low beta (0.39) and negative momentum; traders would likely find better opportunities elsewhere. It is potentially suitable for long-term investors (3-5 year horizon) who believe in the fundamental value proposition and are willing to endure volatility for a potential turnaround. The company's stable cash flows and dividend support a long-term income-oriented hold. Given the current technical damage and uncertainty, a minimum holding period of 12-18 months is suggested to allow for a potential operational or sentiment recovery.